» Articles » PMID: 28179596

Nephron, Wilms' Tumor-1 (WT1), and Synaptopodin Expression in Developing Podocytes of Mice

Overview
Journal Exp Anim
Date 2017 Feb 10
PMID 28179596
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Newborn mouse glomeruli are still immature with a morphological feature of an early capillary loop stage, but infant mice do not manifest proteinuria. Little is known about the molecular mechanism whereby infant mice are resistant to proteinuria. Nephrin and synaptopodin are crucial for slit diaphragm and foot process (FP) formation for avoiding proteinuria. Nephrin tyrosine phosphorylation means a transient biological signaling required for FP repair or extension during nephrotic disease. Using an immunohistochemical technique, we examined the natural course of nephrin, Wilms' tumor-1 (WT1) and synaptopodin at 16.5 days of embryonic age (E16.5d) and E19.5d, 7 days of post-neonatal age (P7d) and P42d during renal development of mice. As a result, nephrin and synaptopodin were detected at E19.5d in S-shaped bodies. WT1, a transcriptional factor for nephrin, was detected in nucleus in podocyte-like cells in all stages. Nephrin tyrosine phosphorylation was evident in glomeruli at P7d, and this was associated with an early-stage of FP extension. Inversely, nephrin phosphorylation became faint at P42d, along with maturated FP. Based on the present results, we suggest the sequential molecular mechanism to protect growing mice from proteinuria: (i) WT1-induced nephrin production by podocytes in S-shaped bodies at E19.5d; (ii) Synchronized induction of synaptopodin at the same period; and (iii) FP extension is initiated at a milk-suckling stage under a nephrin tyrosine-phosphorylated condition, while it is arrested at an adult stage, associated with a loss of nephrin-based signaling.

Citing Articles

Development of Drug Efficacy Testing Platform for Glomerulonephritis.

Kwon E, Choi Y, Kim S, Park S, Yun G, Min S Micromachines (Basel). 2024; 15(3).

PMID: 38542564 PMC: 10971927. DOI: 10.3390/mi15030317.


The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury.

Zhao S, Feng J, Li J, Cao R, Zhang Y, Yang S Ann Transl Med. 2021; 9(16):1303.

PMID: 34532440 PMC: 8422093. DOI: 10.21037/atm-21-3577.


Spatio-temporal patterning of different connexins in developing and postnatal human kidneys and in nephrotic syndrome of the Finnish type (CNF).

Kosovic I, Filipovic N, Benzon B, Vukojevic K, Saraga M, Glavina Durdov M Sci Rep. 2020; 10(1):8756.

PMID: 32471989 PMC: 7260365. DOI: 10.1038/s41598-020-65777-5.


Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats.

Li B, Xiao X, Miao Y, Guo L, Zhen J, Li X Exp Ther Med. 2019; 19(1):123-130.

PMID: 31853281 PMC: 6909629. DOI: 10.3892/etm.2019.8178.

References
1.
Yamada K, Kurosawa T, Okamoto M, Yue B, Mizuno S, Naiki M . [Pathogenesis of spontaneous nephrosis in mice--urinary protein in nephrotic mice]. Jikken Dobutsu. 1994; 43(4):527-34. DOI: 10.1538/expanim1978.43.4_527. View

2.
Sorokin L, Ekblom P . Development of tubular and glomerular cells of the kidney. Kidney Int. 1992; 41(3):657-64. DOI: 10.1038/ki.1992.101. View

3.
Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C . Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol. 2008; 294(5):F1185-94. DOI: 10.1152/ajprenal.00442.2007. View

4.
Quaggin S, Kreidberg J . Development of the renal glomerulus: good neighbors and good fences. Development. 2008; 135(4):609-20. DOI: 10.1242/dev.001081. View

5.
Kato T, Mizuno S, Nakamura T . Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice. Nephrology (Carlton). 2011; 16(3):310-8. DOI: 10.1111/j.1440-1797.2010.01392.x. View